Acadian Asset Management LLC Galapagos Nv Transaction History

Acadian Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$24.78 - $32.48 $355,394 - $465,828	-14,342 Reduced 94.44%	844 $20,000
Q1 2024 May 10, 2024	BUY	$32.2 - $42.44 $76,185 - $100,413	2,366 Added 18.46%	15,186 $488,000
Q4 2023 Feb 13, 2024	SELL	$31.87 - $40.71 $201,705 - $257,653	-6,329 Reduced 33.05%	12,820 $520,000
Q3 2023 Nov 13, 2023	BUY	$34.17 - $42.98 $415,302 - $522,378	12,154 Added 173.75%	19,149 $661,000
Q2 2023 Aug 07, 2023	BUY	$37.4 - $44.52 $139,202 - $165,703	3,722 Added 113.72%	6,995 $284,000
Q1 2023 May 11, 2023	BUY	$36.5 - $48.0 $119,464 - $157,104	3,273 New	3,273 $126,000
Q2 2022 Aug 09, 2022	SELL	$52.3 - $71.59 $21,547 - $29,495	-412 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$51.32 - $68.5 $21,143 - $28,222	412 New	412 $25,000
Q2 2021 Aug 11, 2021	SELL	$68.86 - $83.34 $970,030 - $1.17 Million	-14,087 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$76.15 - $111.94 $1.07 Million - $1.58 Million	14,087 New	14,087 $1.09 Million
Q4 2020 Feb 11, 2021	SELL	$96.85 - $148.25 $3.85 Million - $5.89 Million	-39,725 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$122.47 - $213.56 $3.63 Million - $6.33 Million	-29,657 Reduced 42.74%	39,725 $5.64 Million
Q2 2020 Aug 12, 2020	SELL	$185.52 - $231.25 $880,106 - $1.1 Million	-4,744 Reduced 6.4%	69,382 $13.7 Million
Q1 2020 May 11, 2020	BUY	$143.0 - $274.03 $4.02 Million - $7.71 Million	28,146 Added 61.21%	74,126 $14.5 Million
Q4 2019 Feb 06, 2020	BUY	$146.12 - $215.82 $6.72 Million - $9.92 Million	45,980 New	45,980 $9.51 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.84B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.